Parkinson’s disease in the acute hospital

Jones, Siôn; Hindle, John V.

doi:10.7861/clinmedicine.11-1-84

Cited by 14 publications

(10 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…A range of specialist and non-specialist multidisciplinary healthcare professionals are responsible for the care provision of those with Parkinson's disease within hospitals (Jones and Hindle, 2011). Participants expressed particular concern with the knowledge of unqualified nursing staff: 'most of the care being done by the nurses or HCAs (health care assistants), you know, HCAs are feeding our patients, positioning our patients, helping mobilise our patients, they doing a lot a lot of our nursing care, and their understanding of Parkinson's disease will probably be very limited, and that's no fault from them, that's the band they are and that's the job that they do, but they are the people who are doing all of our care throughout the twenty four hours of the day for these patients that and that's where The repetition of the word "our" appears to emphasise the degree to which a physiotherapist may feel ownership, or responsibility for the treatment of a patient.…”

Section: Challenges To Application Of Care Variance In Knowledge Levementioning

confidence: 99%

Physiotherapists' experiences of respiratory compromise in patients with Parkinson's disease: A qualitative study

Walker

Cross²

2018

International Journal of Therapy and Rehabilitation

View full text Add to dashboard Cite

Background/Aims: To explore the experiences and perceptions of physiotherapists involved in the care of people with Parkinson's disease and respiratory compromise. Methods: This exploratory qualitative study recruited four physiotherapists who participated in a focus group and completed reflective diaries over a 3-month period. Experiences were explored using Interpretative Phenomenological Analysis. Findings: The study highlights three key themes: application of professional knowledge, application of clinical decision making and challenges to application of care. Conclusions: The results demonstrate sensitive awareness in caring for a dependent and vulnerable population whose key motor signs, compounded by ageing are perceived as influencing the presentation of respiratory compromise. There are descriptions of a reactive response to illness, alongside reflections on the challenges faced when asserting autonomy and recognising where the role of physiotherapy fits within the multidisciplinary team. Sputum clearance is perceived as being a key aspect of this role, although there is uncertainty with regard to the effectiveness and appropriateness of treatment options. Multiple perceived challenges to care provision are highlighted, with key concerns surrounding clinician and patient 2 knowledge levels, maintenance of patient mobility, person centred care and clarity in the direction of care.

show abstract

Section: Challenges To Application Of Care Variance In Knowledge Levementioning

confidence: 99%

Physiotherapists' experiences of respiratory compromise in patients with Parkinson's disease: A qualitative study

Walker

Cross²

2018

International Journal of Therapy and Rehabilitation

View full text Add to dashboard Cite

show abstract

“…Las cuatro manifestaciones clínicas principales son: hipertermia, rigidez muscular severa, disfunción del sistema nervioso autónomo y alteración del nivel de conciencia. Los hallazgos de laboratorio consisten en elevación de los niveles plasmáticos de (8) creatinkinasa y leucocitosis . El mecanismo fisiopatológico por el que se produce sigue siendo desconocido.…”

Section: Las Vías Dopaminérgicasunclassified

Neuroleptic malignant-like síndrome

Vera

Denis

Recalde

et al. 2017

Rev. virtual Soc. Parag. Med. Int

View full text Add to dashboard Cite

RESUMENEl síndrome neuroléptico maligno like o crisis acinética es una rara y potencialmente letal complicación del abandono de medicación de los pacientes con enfermedad de Parkinson. Se presenta el caso clínico de un paciente de sexo masculino de 52 años de edad, con antecedente de enfermedad de Parkinson de 10 años de evolución que se encuentra en tratamiento con levodopa-carbidopa. Acude a consultar por disminución del estado de conciencia y rigidez muscular generalizada, relacionado con el abandono de medicación 7 días antes del inicio de los síntomas. Palabras claves: síndrome neuroléptico maligno, enfermedad de Parkinson, receptores dopaminérgicos, dopaminérgicos ABSTRACTNeuroleptic malignant-like syndrome or akinetic crisis is a rare and potentially lethal complication of the withdrawal of medication of patients with Parkinson's disease. We present the clinical case of 52-year man with 10-year history of Parkinson's disease who is being treated with levodopa-carbidopa. He consults for decreased level of consciousness and general muscular rigidity, related to the withdrawal of the medication 7 days before the onset of symptoms. Keywords: neuroleptic malignant syndrome, Parkinson's disease, dopaminergic receptors, dopaminergic drugs INTRODUCCIÓNEl síndrome neuroléptico maligno (SNM) es una complicación rara, pero potencialmente letal, de la utilización de medicamentos antipsicóticos. Es el resultado de una compleja interacción entre la (1) medicación neuroléptica y alguna clase de susceptibilidad . El mecanismo fisiopatológico probablemente se deba al bloqueo de receptores de dopamina a nivel de sistema nervioso central. Esto se ha respaldado en evidencias tales como la asociación con los medicamentos cuyo mecanismo de acción es el bloqueo de receptores dopaminérgicos en el sistema nervioso central, la mayor incidencia entre más fuerte sea la

show abstract

“…In particular problems in mobility and communication affect more than 80% of patients, weakness, spasms and bowels problems more than 50% and very frequent are also pain, psychiatric symptoms, sleep disturbance and bladder disorders (11,12). The continuation of treatments may be important to minimise symptoms -for instance ensuring that dopaminergic medication continues for a patient with PD, and this may necessitate the use of a naso-gastric tube or transdermal preparations (13). There may also be treatments for patient with PD, such as deep brain stimulation or apomorphine infusions that may need to be continued as the patient deteriorates to reduce the risks of motor complications (14), although consideration may also need to be given to withdrawal of treatment if there is no ongoing benefit.…”

Section: Physical Issuesmentioning

confidence: 99%